Bioprocessing - Upstream & Downstream

It is time to rethink traditional approaches to biosafety.

We must never forget unmet needs when developing new medicines.

After a vibrant year of advances in pharmaceutical development and manufacturing technologies, we present The Medicine Maker 2019 Innovation Awards.

More complex proteins are coming down the pipe! Next-generation protein expression will require a toolbox of next-generation solutions.

With the focus on next generation bioprocessing, it is important that manufacturers do not forget to re-examine their approach to viral safety.

Step into the design space and your life will be changed forever.

Tony Hitchcock discusses his career and the evolution of the gene therapy market.

Gene is excited about the hot new trend in process development...

Higher productivity, lower hold times, lower costs… continuous processing for monoclonal antibodies could offer a number of advantages.

There could be significant benefits to implementing additional measures in upstream bioprocesses to prevent viral contamination.